StockWatch
·

RAMA PHOSPHATES LTD. Q1 FY27 Results

RAMAPHOQ1 FY27 Results
Filing
Result:Steady· Market: UpMargin squeeze
MetricValueQ4 FY26Q1 FY26
Revenue224.80 Cr2.6%18.1%
Total Income225.55 Cr2.6%18.1%
Expenditure202.74 Cr4.8%19.6%
PBT22.81 Cr233.3%6.3%
Net Profit17.06 Cr218.0%6.4%
OPM12.41%7.84pp1.41pp
NPM7.57%5.13pp0.83pp
EPS4.82217.1%6.4%
View full financials

Revenue grew a healthy 18.1% YoY but OPM (13.8%→12.4%) and NPM (8.4%→7.6%) compressed, limiting adjusted PAT growth to just 6.4%, an in-line quarter with no real quality upside.

Q1 FY-2027 RESULTS · RAMAPHO

Rama Phosphates Q1: revenue up 18% YoY but margin squeeze holds PAT growth to 6%

PAT +6.4% YoY · revenue +18.1% · margins compressing

24 Jul 2026 · 3 min read
Revenue

₹224.8 Cr

+18.1% YoY

PAT (standalone)

₹17.06 Cr

+6.4% YoY

Net margin

7.56%

-0.8pp YoY

EPS

₹4.82

Rama Phosphates opened FY27 with an 18.1% YoY jump in standalone revenue to ₹224.80 Cr, but net profit rose just 6.4% to ₹17.06 Cr — the gap is the whole story of the quarter. Growth was volume/price-led in the core Fertilizers, Micro Nutrients & Chemicals segment (revenue ₹221.23 Cr, +25% YoY), while the small Soya/Agri segment collapsed to ₹3.57 Cr from ₹13.91 Cr a year ago and slipped to a ₹0.28 Cr segment loss.

The scoreboard

Q1 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹224.8 Cr+2.6%+18.1%
Expenses₹202.74 Cr-4.8%+19.6%
PAT₹17.06 Cr+218%+6.4%
Net margin7.56%+5.1pp-0.8pp
EPS₹4.82+217.1%+6.4%

The profit lag is a margin problem, not a demand problem. Cost of materials consumed climbed to ₹171.36 Cr (+32.5% YoY) — outpacing revenue — and finance cost rose to ₹4.05 Cr, compressing net margin to 7.59% from 8.40% a year ago and pulling operating margin down to roughly 12.7% from ~13.8%. The optical 218% sequential jump in PAT (from ₹5.37 Cr in Q4 FY26) is a low-base artifact: Q4 carried a weak ₹684.50 lakh pre-tax print, so the QoQ leap flatters and should not be read as momentum. There are no exceptional or extraordinary items on either side, so reported and adjusted growth are identical (+6.4% YoY).

116.28123.31130.34137.37144.4134.504-2005-1306-0807-0207-24Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹134.5, down 1.1% over the past month of trading.

₹ Cr
06.4512.919.365.25Q4 FY25rev ₹201 Cr16.03Q1 FY26rev ₹190 Cr17.28Q2 FY26rev ₹246 Cr14.03Q3 FY26rev ₹238 Cr5.37Q4 FY26rev ₹219 Cr17.06Q1 FY27rev ₹225 Cr
Quarterly standalone PAT, ₹ Crore
Beyond the headline

What the summary numbers don't show

EPS ₹4.82 (vs ₹4.53 YoY) — tax ₹5.75 Cr, finance cost up to ₹4.05 Cr from ₹3.52 Cr

There is no formal management guidance on record and no brokerage consensus for a company this size; the only external marker is analyst commentary (MarketsMojo) watching for operating margin to stabilise above 8% — a bar this quarter's ~12.7% OPM clears comfortably even as margins fell YoY. Against the board's own release, the disclosed net profit (₹1,706.44 lakh) and pre-exceptional operating profit (₹2,281.23 lakh) match the statement exactly. The quarter also sets up near-term capacity news: management flags trial production at the new Dhule greenfield SSP plant by end-September 2026 and a 65,000 MTPA SSP expansion at Udaipur, which take the company's overall SSP capacity toward 9,79,000 MTPA.

  • W1

    Whether net margin recovers toward the 8%+ level analysts flagged, or raw-material cost inflation (+32.5% YoY) keeps compressing it next quarter

  • W2

    Dhule greenfield SSP plant — trial production guided for end-September 2026; commissioning slippage is the key capex checkpoint

  • W3

    Soya/Agri segment recovery after revenue collapsed 74% YoY to ₹3.57 Cr and turned loss-making

Clean digital PDF, ₹ lacs converted to ₹ Cr. No exceptional/extraordinary items either period. Standalone-only — company has no subsidiaries/associates (Note 3), so no consolidated statement exists. All arithmetic ties: TI=Rev+OI, PBT=TI−TotExp, PAT=PBT−Tax. Q4FY26 column is a balancing figure per auditor Other Matters note.

Informational and educational content only. Not investment advice.

RAMA PHOSPHATES LTD. (RAMAPHO) Q1 FY27 Results — StockWatch